Entity Common Stock, Shares Outstanding of Citius Pharmaceuticals, Inc. from 23 Aug 2011 to 17 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Citius Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 23 Aug 2011 to 17 Dec 2025.
  • Citius Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 17 Dec 2025 was 20,762,917, a 169% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Citius Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 20,762,917 +13,035,674 +169% 17 Dec 2025 10-K/A 28 Jan 2026 2025 FY
Q2 2025 17,012,191 -163,713,216 -91% 11 Aug 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 10,290,335 -170,383,020 -94% 09 May 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 7,727,243 -151,239,333 -95% 18 Dec 2024 10-K/A 27 Jan 2025 2024 FY
Q2 2024 180,725,407 +21,867,609 +14% 12 Aug 2024 10-Q 12 Aug 2024 2024 Q3
Q1 2024 180,673,355 +21,815,557 +14% 10 May 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 158,966,576 +12,755,446 +8.7% 27 Dec 2023 10-K 29 Dec 2023 2023 FY
Q2 2023 158,857,798 +12,728,168 +8.7% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 158,857,798 +12,728,168 +8.7% 10 May 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 146,211,130 +181,500 +0.12% 15 Dec 2022 10-K 22 Dec 2022 2022 FY
Q2 2022 146,129,630 +150,201 +0.1% 10 Aug 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 146,129,630 +10,655,683 +7.9% 10 May 2022 10-Q 12 May 2022 2022 Q2
Q4 2021 146,029,630 +90,452,634 +163% 30 Nov 2021 10-K 15 Dec 2021 2021 FY
Q2 2021 145,979,429 +90,503,607 +163% 10 Aug 2021 10-Q 12 Aug 2021 2021 Q3
Q1 2021 135,473,947 +97,345,885 +255% 10 May 2021 10-Q 13 May 2021 2021 Q2
Q4 2020 55,576,996 +26,646,503 +92% 30 Nov 2020 10-K 16 Dec 2020 2020 FY
Q2 2020 55,475,822 +33,400,041 +151% 10 Aug 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 38,128,062 +16,052,281 +73% 11 May 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 28,930,493 +11,131,702 +63% 09 Dec 2019 10-K 16 Dec 2019 2019 FY
Q2 2019 22,075,781 +5,876,990 +36% 07 Aug 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 22,075,781 +11,398,559 +107% 08 May 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 17,798,791 +9,375,400 +111% 01 Dec 2018 10-K 11 Dec 2018 2018 FY
Q2 2018 16,198,791 +7,945,993 +96% 13 Aug 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 10,677,222 -64,827,020 -86% 08 May 2018 10-Q 11 May 2018 2018 Q2
Q4 2017 8,423,391 -65,689,669 -89% 01 Dec 2017 10-K 13 Dec 2017 2017 FY
Q2 2017 8,252,798 -64,785,262 -89% 08 Aug 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 75,504,242 30 Apr 2017 10-Q 15 May 2017 2017 Q2
Q4 2016 74,113,060 +39,411,840 +114% 01 Dec 2016 10-K 23 Dec 2016 2016 FY
Q2 2016 73,038,060 +39,270,183 +116% 10 Aug 2016 10-Q 15 Aug 2016 2016 Q3
Q4 2015 34,701,220 +4,675,934 +16% 01 Dec 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 33,767,877 +15,767,877 +88% 07 Aug 2015 10-Q 13 Aug 2015 2015 Q3
Q1 2015 32,422,507 +14,422,507 +80% 08 May 2015 10-Q 13 May 2015 2015 Q2
Q4 2014 30,025,286 +12,025,286 +67% 19 Dec 2014 10-KT 29 Dec 2014 2014 FY
Q2 2014 18,000,000 13 Aug 2014 10-Q 14 Aug 2014 2014 Q3
Q1 2014 18,000,000 0 0% 15 May 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 18,000,000 0 0% 31 Jan 2014 10-K 06 Feb 2014 2013 FY
Q3 2013 18,000,000 09 Sep 2013 10-Q 18 Sep 2013 2013 Q3
Q1 2013 18,000,000 0 0% 01 May 2013 10-Q 13 May 2013 2013 Q2
Q4 2012 18,000,000 0 0% 04 Jan 2013 10-K 15 Jan 2013 2012 FY
Q2 2012 18,000,000 31 Jul 2012 10-Q 17 Aug 2012 2012 Q3
Q1 2012 18,000,000 20 Apr 2012 10-Q 11 May 2012 2012 Q2
Q4 2011 18,000,000 05 Jan 2012 10-K 13 Jan 2012 2011 FY
Q3 2011 18,000,000 23 Aug 2011 10-Q 26 Aug 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.